ChartRow logo
Data provided bySource: Twelve Data
DVA
$191.35-1.78%
as of close, Nov 6, 2026
☾ AH $191.35 -1.78%
PeersUHSFMSENSGEHCTHCKHC
Share this page

DVA — DaVita Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
Data provided bySource: Twelve Data
What would $1,000 invested in DVA be worth today? →
DVA returns: By year · By month · By week · Trailing

Price data

Price
$191.35
YTD price return
+68.43%
YTD total return
+68.43%
Market cap
12B
Enterprise value
25.3B
Shares outstanding
62.9M
52W low
$101.00
52W high
$247.49
From 52W high
-22.68%
From 52W low
+89.46%
52W range
62%$101–$247
Beta
0.86

Volume

Rel volume
0.81×
30D volume
741.2K
30D $ vol
136M

Insider trading

Insider net 1W
none
Insider net 1M
−$69.0M
Insider net 3M
−$69.0M
Insider net 1Y
−$523.4M

Form 4 transactions by trade date, as filed; latest on file 2026-10-27.

Fundamentals

Sales (ttm)
14.2B
Sales/share
$225.24
EPS (ttm)
$13.55
FCF (ttm)
1.3B
FCF/share
$20.57
Book value/share
-$9.40
Net margin
6.49%
ROA
5.16%
Current ratio
1.41

Growth (CAGR, ttm) · 10Y

Sales
+6.38%+5.95%+4.12%+2.91%
Net income
+19.21%+14.74%-0.94%+2.54%
FCF
+0.11%-0.53%+1.36%+1.66%
Shares
-10.91%-11.68%-9.20%-10.81%

Per-share growth (CAGR, ttm) · 10Y

EPS
+38.77%+27.39%+9.54%+14.63%
Sales/share
+19.42%+19.96%+14.66%+15.56%
FCF/share
+12.37%+12.62%+11.63%+13.98%
Price
+57.50%+34.31%+11.83%+12.55%
Total return
+57.50%+34.31%+11.83%+12.55%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
14.1×
P/OI (ttm)
5.7×
Fwd P/E
11.3×
P/S (ttm)
0.8×
P/B (mrq)
-20.4×
P/FCF (ttm)
9.3×
EV/EBITDA (fy)
9.0×
EV/Sales (ttm)
1.8×
FCF yield (ttm)
10.75%
Buyback yield (realized, 1y)
10.91%
Shareholder yield (realized, 1y)
10.91%
Buyback yield (cash, ttm)
9.96%
Shareholder yield (cash, ttm)
9.96%

Vs own 10Y history

P/E
39th
P/OI
36th
P/S
47th
P/B
98th
P/FCF
60th

Bar = where today’s multiple sits in DVA’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-06#

Data provided bySource: Twelve Data
1D
-1.78%
5D
+2.05%
1M
+6.07%
3M
+5.91%
YTD
+68.43%
1Y
+57.45%
5Y
+74.97%
1D
-1.78%
5D
+2.05%
1M
+6.07%
3M
+5.91%
YTD
+68.43%
1Y
+57.45%
5Y
+74.97%

Fundamentals#

Revenue

5Y CAGR +3.4%5Y CAGR +3.4%YoY +4.6%
$14.2B TTM$3.6B Q3 '26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR +3.8%10Y CAGR +6.0%YoY −1.3%
$2.1B TTM$499.3M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR +9.3%10Y CAGR +22.9%YoY +66.7%
$13.55 TTM$3.40 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR +0.1%10Y CAGR +4.4%YoY −46.8%
$1.3B TTM$359.3M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM

TTM: operating cash flow $1.9B, capex −$576.8M

Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q3 2026: operating cash flow $518.8M, capex −$159.5M

Shares (diluted)

5Y −38.1%10Y −64.9%YoY −11.2%
67.9M TTM65.5M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR −0.7%10Y CAGR +10.7%YoY +48.3%
$920.1M TTM$222.9M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Full DVA financials →

DaVita Inc. is a healthcare services company focused on kidney care, with its core business centered on outpatient dialysis for patients living with chronic kidney disease and end-stage renal disease. DaVita provides in-center hemodialysis, peritoneal dialysis, and home dialysis options, along with related clinical support and care coordination services. The company also operates integrated kidney care programs and offers ancillary services that support treatment management and patient care across the kidney health journey. With a large network of dialysis centers in the United States and international markets, DaVita plays a major role in delivering life-sustaining renal care and serving healthcare systems, insurers, and patients who require ongoing treatment.

Denver, CO·78,000 employees·Medical Care Facilities·davita.com·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding DVA#

30 of the 193 ETFs ChartRow carries live hold DVA. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
RSPInvesco S&P 500 Equal Weight ETF0.2%
VBRVanguard Small-Cap Value ETF0.2%
XLVHealth Care Select Sector SPDR Fund0.1%
VBVanguard Small-Cap ETF0.1%
VHTVanguard Health Care ETF0.1%
IWSiShares Russell Mid-Cap Value ETF0.1%
IWRiShares Russell Midcap ETF0.1%
SPYVSPDR Portfolio S&P 500 Value ETF0.0%
TickerName1M1D
LLYEli Lilly and Company+16.98%-0.79%
JNJJohnson & Johnson+8.42%+1.43%
ABBVAbbVie Inc.+9.23%+1.07%
MRKMerck & Co. Inc.+3.37%-0.14%
UNHUnitedHealth Group Incorporated Common Stock (DE)+4.74%-0.40%
NVSNovartis AG+15.46%+0.38%
TMOThermo Fisher Scientific Inc.+5.81%+2.63%
AMGNAmgen Inc.+14.36%+0.03%